Navigation Links
Surprising findings reported about iron overload

UAB and international scientists studying iron-overload disorders have made the unexpected discovery that Asians and Pacific Islanders have the highest levels of iron in their blood of all racial/ethnic groups who were screened.

Individuals who develop hemochromatosis/iron overload absorb an excessive amount of iron from food and supplements ingested. The abnormality affects many people worldwide, is prevalent in the South, and sometimes causes organ damage when severe iron deposition occurs due to inadequate control of iron absorption by the small intestine.

The first major report of findings in the five-year, 100,000-person study will be published tomorrow, April 28, in The New England Journal of Medicine (NEJM). The University of Alabama at Birmingham received $3.1 million of study funds to screen 20,000 people for the group of disorders called hemochromatosis and iron overload.

Ronald T. Acton, Ph.D., professor of microbiology and director of the UAB Immunogenetics Program, is principal investigator for the Birmingham Field Center that did the screening. James C. Barton, M.D., director of the Southern Iron Disorders Center and UAB clinical professor of medicine, is co-principal investigator. They exceeded the goal of screening 10,000 African-Americans and 10,000 whites for blood iron levels or the presence of mutations in a gene, called the HFE gene, which evidence suggests regulates iron absorption.

"Hemochromatosis and iron overload are easily treatable if diagnosed early, but the simple blood test that could detect these conditions is not performed as part of routine medical exams," said Acton. Delaying treatment ?the weekly removal of a pint of blood by phlebotomy ?can permit the progressive accumulation of iron deposits in target organs that may result in complications such as cirrhosis of the liver, liver cancer, arthritis, diabetes, impotence and heart failure.

"The finding that Asians and Pacific Islanders have high
'"/>

Source:University of Alabama at Birmingham


Page: 1 2 3

Related biology news :

1. An HIV Protein Plays a Surprising Role in Gene Activation
2. Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research
3. Surprising symbiosis: Glassy-winged sharpshooter eats with friends
4. Study findings offer potential new targets for antibiotics
5. Oops! Researchers publish new findings on the brains response to costly mistakes
6. Biodiversity key to sustainable biofuel according to University of Minn. researchers findings
7. New findings offer more complete view of breast cancer gene mutations in US population
8. New stem-cell findings can help the body to cure itself
9. New findings could lead to vaccine for severe malaria
10. New findings blow a decade of assumptions out of the water
11. New lead reported in tumor angiogenesis

Post Your Comments:
(Date:11/23/2009)...for 360 million years and survived when the dinosa...g to make many of them extinct, according to an ar... . , The fungus, Batrachochytrium dendrobatidi...amphibian extinctions in Central America and north...350 amphibian species by penetrating their skin, b...
(Date:11/23/2009)...x-week-old turkey poults could save millions of ma...ccording to Dr. Gerald Steiner from the Dresden Un...eir use of infrared spectroscopy to determine the ...accurate method with the potential to be used by t... eggs for breeding. The pilot study has just been ...
(Date:11/23/2009)... Interuniversity Professorship in Law and the Huma...of the Basque Country. The Professorship is largel...ch as researchers in the fields of molecular biolo...he Interuniversity Professorship in Law and the Hu...Basque Country was created in 1993. The worldwide ...
Breaking Biology News(10 mins):Rescuing male turkey chicks 2Research and legislation should go hand in hand, as much as possible 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 1Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 2Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 3Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 4Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 5Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 6Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 7Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 8Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 9Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 10Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 11Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 12Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 13Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 14Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 15Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 16Inverness Medical Innovations Announces Third Quarter 2009 Results 5731 17Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 1Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 2Intercept Pharmaceuticals Announces Positive Phase II Results for INT 747 as a Treatment for Primary Biliary Cirrhosis 5726 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 1Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 2Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 3Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy 26apos 3Bs Video Base 60135 4
...in, reward and addictive behaviors. Opioids exert ... receptors, mu, delta and kappa whose genes have b...Opioid receptors in the brain are activated by a f...orphins and endorphin, which are released by neuro...usly by alkaloid opiates, the prototype of which i...
...ry J. Hannon, Ph.D., Cold Spring Harbor Laboratory...ute (HHMI) investigator, along with two other youn...rial Sloan-Kettering Cancer Centers (MSKCC) 2007 P... named after Paul A. Marks, Ph.D., President Emeri... to the basic understanding and treatment of cance...
...m aimed at linking together the world,s databases ... the Nobel Prize for Medicine awarded to Mario R. ... launched this week. , The Cambridge University... will ultimately support new medical advances and ...esearch. , Because they are so genetically simila...
Other Biology News:How does the opioid system control pain, reward and addictive behavior? 2How does the opioid system control pain, reward and addictive behavior? 3How does the opioid system control pain, reward and addictive behavior? 4Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer 2A computer for your mouse! 2
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...need is a good idea to make some good money. You c...me registration for a year for much less than $1 a...per month. For an additional $3 a month, get an en...fer secure online credit-card transactions. Cha-ch...n in for free. In principle you will have almost t...
...s. The Madison police department has moved to sp...ddition of an eToken USB key system provided by A...vide a robust and dependable situation thats easil...focus on protecting the city of Madison with unpar...on, said Neil Sullivan, the companys enterprise se...
...fices are located in the MG&E Innovation Center at...al research group ConjuGon announced on Tuesday ...of $1.1 million dollars from angel investors, incl...e new funds will be directed to the firms operatin...otheraputic treatments. , ,ConjuGon develops remed...
Other Biology Technology:The Wal-Mart-ization of e-commerce 2The Wal-Mart-ization of e-commerce 3Madison police adopt digital lock and key 2ConjuGon lands $1 million angel investment 2
Rabbit Anti-Potassium Channel kv3.2 Antibody, Unconjugated from Spring Bioscience
Sheep Anti-Human ErbB 2 Polyclonal Antibody, Unconjugated from Abcam
Hybridization Solution, 2 Concentrate, Buffered with SSPE from Sigma-Aldrich
Rabbit Anti-Rat Potassium Channel Kv2.2 Antibody, Unconjugated from CHEMICON
Biology Products: